Innoviva, Inc. (INVA)
22.95
-0.07
(-0.30%)
USD |
NASDAQ |
Apr 07, 10:09
Innoviva Total Assets (Quarterly) : 1.635B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 136.87B |
| Cytokinetics, Inc. | 1.425B |
| Nektar Therapeutics | 280.41M |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Oramed Pharmaceuticals, Inc. | 230.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 462.32M |
| Shareholders Equity (Quarterly) | 1.173B |
| Debt to Equity Ratio | 0.2294 |
| Current Ratio | 14.64 |
| Net Debt Paydown Yield | 2.44% |